Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2023-09-15 00:00:00 ET · period of report 2023-09-15 · accession 0001209191-23-049648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-09-15 | 2023-09-15 | AXSM | Coleman Mark | Dir | S - Sale+OE | $75.18 | -18.6K | 403.9K | -4% | -$1.40M |
| D | 2023-09-15 | 2023-09-15 | AXSM | Coleman Mark | Dir | M - OptEx | $3.67 | +11.0K | 36.1K | +44% | +$40.4K |
| D | 2023-09-15 | 2023-09-15 | AXSM | Coleman Mark | Dir | S - Sale+OE | $75.19 | -11.0K | 25.1K | -31% | -$828.3K |
| D | 2023-09-15 | 2023-09-15 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -11.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | S | D | 18,572 | $75.18 | 403,856 | I | — | — | |
| 2 | Common | Common Stock | 2023-09-15 | M | A | 11,016 | $3.67 | 36,113 | D See Footnote | — | — | (F4) Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares. |
| 3 | Common | Common Stock | 2023-09-15 | S | D | 11,016 | $75.19 | 25,097 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-09-15 | M | D | 11,016 | $0.00 | 0 | D | $3.67 · 2015-09-16 to 2024-09-16 | 11,016 Common Stock |